Karl H Donn

Parion Sciences, Inc.

$5,675,779

Attributed

$6,960,352

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2M · FY2008–25

$2M$1.5M$1M$500K$0

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$6,960,352 · 6

By mechanism

R44$4,836,595 · 3

RC1$1,690,320 · 1

R43$433,437 · 2

Top collaborators

David Busick1 shared
Benjamin Yerxa1 shared

Most similar at Parion Sciences, Inc.

Same institution · by research overlap

Benjamin Yerxa$774,660

Others in their field

Top investigators on “Surface”

David Divins · Consortium For Ocean Leadership, Inc$609,772,544
Mitchell J Malone · Texas A&M Research Foundation$320,373,312
Gary D Acton · University Of California-Davis$320,373,312
Lawrence Corey · Fred Hutchinson Cancer Center$207,726,216
Kiyoshi Suyehiro · Iodp Management International, Inc$166,539,344
Sharon L Hillier · Magee-Women'S Hospital Of Upmc$118,664,913

Research focus

SurfaceSafetyHydration StatusLungDrug FormulationsDoseInflammationLeadMucociliary ClearanceAerosolsChronicToxicologyAnimalsTherapeutic AgentsClinical TrialsDesignEpitheliumScienceSolutionsLung DiseasesMediatingInfectionEtiologyLiquid Substance

Grant awards (9)

A Novel ENaC Blocker/Osmolyte Inhalation Solution for the Treatment of Muco-Obstructive Lung Diseases$1,971,749

R44 · FY2025 · HL · contact PI

A Novel ENaC Blocker/Osmolyte Inhalation Solution for the Treatment of Muco-Obstructive Lung Diseases$295,700

R44 · FY2024 · HL · contact PI

Novel Dual Acting Antibiotics for Pulmonary Disease$274,173

R43 · FY2020 · AI · contact PI

Hypertonic Saline for Cystic Fibrosis$1,509,420

R44 · FY2013 · HL · contact PI

The Development Epithelial Sodium Channel Blockers for Chronic Dry Eye$1,059,726

R44 · FY2011 · EY · contact PI

Novel Therapies for Enhancing Clearance of Inhaled Radioactive Particles$340,009

RC1 · FY2010 · AI · contact PI

The Development Epithelial Sodium Channel Blockers for Chronic Dry Eye$159,264

R43 · FY2010 · EY · contact PI

Novel Therapies for Enhancing Clearance of Inhaled Radioactive Particles$500,000

RC1 · FY2009 · AI · contact PI

Novel Therapies for Enhancing Clearance of Inhaled Radioactive Particles$850,311

RC1 · FY2008 · AI · contact PI